The Asia Pacific Ruminant Vaccines Market would witness market growth of 7.4% CAGR during the forecast period (2024-2031).
The China market dominated the Asia Pacific Ruminant Vaccines Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $441.5 million by 2031. The Japan market is registering a CAGR of 6.6% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 8.1% during (2024 - 2031).
Enteric diseases are a common cause of morbidity and mortality in ruminants, leading to gastrointestinal disturbances, diarrhea, and reduced feed efficiency. Vaccines targeting enteric pathogens such as rotavirus, coronavirus, Escherichia coli, Salmonella spp., and Clostridium spp. are used to prevent diseases like calf scours, enterotoxemia (overeating disease), salmonellosis, and colibacillosis. Vaccination helps reduce the prevalence and severity of enteric infections, improve digestive health, and enhance growth performance in young and adult ruminants.
The adoption of vaccines varies across different regions, production systems, and livestock sectors. Several factors influence the adoption of ruminant. For instance, regulatory requirements for disease control, import/export regulations, and market access considerations influence the adoption of vaccination programs. Producers may be required to vaccinate their animals against specific diseases to comply with national or international health standards, gain access to export markets, or participate in disease control programs mandated by regulatory authorities.
Bovine respiratory diseases (BRD) is a widespread and economically significant disease in China’s cattle population. For instance, as per the National Library of Medicine, in China, the incidence of BRD is 50-100%, and the mortality rate is 20-50%. Extreme weather conditions, such as cold winters and temperature fluctuations between spring and autumn in Xinjiang, China, contribute to increased susceptibility of calves to respiratory diseases, including BRD. Also, respiratory illness affects 40-80% of people, with a 60-90% fatality rate. The high prevalence of BRD in China drives the demand for effective vaccines among cattle producers. Furthermore, with India being one of the largest livestock producers globally, the increasing population of ruminants, including cattle, buffalo, sheep, and goats, translates to a higher demand for disease prevention measures. The overall number of livestock in India is 536.76 million, up 4.8% from the 2012 livestock census, according to the Ministry of Fisheries, Animal Husbandry & Dairying. In 2019, there were 303.76 million bovines (buffalo, cow, yak, and mithun) worldwide, a 1.3% rise from the previous census. Hence, the rising livestock population and high rates of BRD in the region are driving the market’s growth.
Based on Animal Type, the market is segmented into Cattle, and Sheep & Goats. Based on Vaccines Type, the market is segmented into Modified/ Attenuated Live, Inactivated (Killed), and Others. Based on Route of Administration, the market is segmented into Injectable, and Intranasal. Based on Indication, the market is segmented into Bovine Respiratory Diseases (BRD), Diarrhea/ Scours, FMD, Clostridial Diseases, Leptospirosis, BVD Infection, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.
The China market dominated the Asia Pacific Ruminant Vaccines Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $441.5 million by 2031. The Japan market is registering a CAGR of 6.6% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 8.1% during (2024 - 2031).
Enteric diseases are a common cause of morbidity and mortality in ruminants, leading to gastrointestinal disturbances, diarrhea, and reduced feed efficiency. Vaccines targeting enteric pathogens such as rotavirus, coronavirus, Escherichia coli, Salmonella spp., and Clostridium spp. are used to prevent diseases like calf scours, enterotoxemia (overeating disease), salmonellosis, and colibacillosis. Vaccination helps reduce the prevalence and severity of enteric infections, improve digestive health, and enhance growth performance in young and adult ruminants.
The adoption of vaccines varies across different regions, production systems, and livestock sectors. Several factors influence the adoption of ruminant. For instance, regulatory requirements for disease control, import/export regulations, and market access considerations influence the adoption of vaccination programs. Producers may be required to vaccinate their animals against specific diseases to comply with national or international health standards, gain access to export markets, or participate in disease control programs mandated by regulatory authorities.
Bovine respiratory diseases (BRD) is a widespread and economically significant disease in China’s cattle population. For instance, as per the National Library of Medicine, in China, the incidence of BRD is 50-100%, and the mortality rate is 20-50%. Extreme weather conditions, such as cold winters and temperature fluctuations between spring and autumn in Xinjiang, China, contribute to increased susceptibility of calves to respiratory diseases, including BRD. Also, respiratory illness affects 40-80% of people, with a 60-90% fatality rate. The high prevalence of BRD in China drives the demand for effective vaccines among cattle producers. Furthermore, with India being one of the largest livestock producers globally, the increasing population of ruminants, including cattle, buffalo, sheep, and goats, translates to a higher demand for disease prevention measures. The overall number of livestock in India is 536.76 million, up 4.8% from the 2012 livestock census, according to the Ministry of Fisheries, Animal Husbandry & Dairying. In 2019, there were 303.76 million bovines (buffalo, cow, yak, and mithun) worldwide, a 1.3% rise from the previous census. Hence, the rising livestock population and high rates of BRD in the region are driving the market’s growth.
Based on Animal Type, the market is segmented into Cattle, and Sheep & Goats. Based on Vaccines Type, the market is segmented into Modified/ Attenuated Live, Inactivated (Killed), and Others. Based on Route of Administration, the market is segmented into Injectable, and Intranasal. Based on Indication, the market is segmented into Bovine Respiratory Diseases (BRD), Diarrhea/ Scours, FMD, Clostridial Diseases, Leptospirosis, BVD Infection, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Boehringer Ingelheim International GmbH
- Zoetis, Inc.
- Merck & Co., Inc.
- Bimeda, Inc.
- Elanco Animal Health, Inc.
- Virbac
- Ceva Sante Animale
- CZ Vaccines S.A.U. (Zendal Health S.A.)
- Indian Immunologicals Ltd. (National Dairy Development Board)
- Vaxxinova International BV (EW Group)
Market Report Segmentation
By Animal Type- Cattle
- Sheep & Goats
- Modified/ Attenuated Live
- Inactivated (Killed)
- Others
- Injectable
- Intranasal
- Bovine Respiratory Diseases (BRD)
- Diarrhea/ Scours
- FMD
- Clostridial Diseases
- Leptospirosis
- BVD Infection
- Others
- China
- Japan
- India
- South Korea
- Australia
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 5. Asia Pacific Ruminant Vaccines Market by Animal Type
Chapter 6. Asia Pacific Ruminant Vaccines Market by Vaccines Type
Chapter 7. Asia Pacific Ruminant Vaccines Market by Route of Administration
Chapter 8. Asia Pacific Ruminant Vaccines Market by Indication
Chapter 9. Asia Pacific Ruminant Vaccines Market by Country
Chapter 10. Company Profiles
Companies Mentioned
- Boehringer Ingelheim International GmbH
- Zoetis, Inc.
- Merck & Co., Inc.
- Bimeda, Inc.
- Elanco Animal Health, Inc.
- Virbac
- Ceva Sante Animale
- CZ Vaccines S.A.U. (Zendal Health S.A.)
- Indian Immunologicals Ltd. (National Dairy Development Board)
- Vaxxinova International BV (EW Group)
Methodology
LOADING...
